Xynomic Pharmaceuticals Stock

xynomicpharma.comHealthcareFounded: 2016Funding to Date: $21.8MM

Xynomic Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing oncology drug candidates.

Register for Details

For more details on financing and valuation for Xynomic Pharmaceuticals, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Xynomic Pharmaceuticals.

Register Today

Team

Management Team

Yinglin Mark Xu
Co-Founder, Chief Executive Officer, President & Chairman
Chasey Zhang
Vice President, Global Strategic Sourcing
Jason Wu Ph.D
Co-Founder & Chief Operating Officer
Jinwei Kou
Interim Chief Accounting Officer
Yong Cui Ph.D
Vice President, CMC

Other companies like Xynomic Pharmaceuticals in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$885.01MM
Sector
 
 

News

Xynomic Pharma, a Dover, DE- and Shanghai, China-based oncology drug development company, completed a Series B crossover financing of undisclosed amount.
/PRNewswire/ -- Xynomic Pharma, a clinical stage US-China oncology drug development company, today announced that it has completed Series B Crossover...